(1-Oxo-2,3-dihydroinden-5-yl)boronic acid, 98%, 25g

7-Benzyloxyindole>98.0%(GC)(N)5g

11-([1,1'-Biphenyl]-3-yl)-11,12-dihydroindolo[2,3-a]carbazole, 97%, 250mg

Báscula analítica y de precisión serie Entris® II Modelos con ajuste externo, no certificados, 0,01 g, 820 g, BCE822-1S

Ethyl 7-bromo-4-oxo-4H-quinolizine-3-carboxylate, 94% HPLC, 100mg

N-Ethyl-N-[(3R)-piperidin-3-yl]propanamide hydrochloride, 1g

5-Nitro-2-piperidin-1-ylaniline, 95+%, 5g

5-(BENZYLOXY)-4-METHOXY-2-METHYLBENZALDEHYDE, 95.0%, 100mg

4-Methoxy-3,5-dimethylbenzonitrile, 95.0%, 1g

5-Methylpyrazin-2-amine, 99.0%, 1g

2-(4-(Tert-butyl)phenyl)piperidine, 97%, 1g

(1R)-1-(4-tert-butylphenyl)ethan-1-amine, 95%, 1g

5-Fluoro-2-methyl-4-nitrophenol, 95%, 100mg